Harmony Biosciences shareholders elect all three Class I directors and ratify Deloitte as auditor

Harmony Biosciences Holdings, Inc.

Jeffrey S. Aronin, R. Mark Graf, and Jeffrey M. Dayno elected as Class I directors with votes ranging from 18.3M to 20.6M for.
Ratification of Deloitte & Touche LLP as independent auditor for 2024 passed with 40.2M votes for, 495k against, 12,722 abstain.
Approximately 40.7M shares (quorum) represented at the 2024 Annual Meeting held May 29, 2024.
All director nominees will serve until the 2027 Annual Meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.